These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6891930)

  • 1. Oestrogen receptors, clinical features and prognosis in stage III breast cancer.
    Stewart JF; King RJ; Winter PJ; Tong D; Hayward JL; Rubens RD
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1315-20. PubMed ID: 6891930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
    Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
    Hawkins RA; White G; Bundred NJ; Dixon JM; Miller WR; Stewart HJ; Forrest AP
    Br J Surg; 1987 Nov; 74(11):1009-13. PubMed ID: 3690224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.
    Williams MR; Todd JH; Ellis IO; Dowle CS; Haybittle JL; Elston CW; Nicholson RI; Griffiths K; Blamey RW
    Br J Cancer; 1987 Jan; 55(1):67-73. PubMed ID: 3814477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
    Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
    Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of prognostic factors in operable breast cancer.
    Hawkins RA; Tesdale AL; Killen ME; Jack WJ; Chetty U; Dixon JM; Hulme MJ; Prescott RJ; McIntyre MA; Miller WR
    Br J Cancer; 1996 Nov; 74(9):1469-78. PubMed ID: 8912547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
    Pichon MF; Broet P; Magdelenat H; Delarue JC; Spyratos F; Basuyau JP; Saez S; Rallet A; Courriere P; Millon R; Asselain B
    Br J Cancer; 1996 Jun; 73(12):1545-51. PubMed ID: 8664127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen receptors and primary breast cancer.
    Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
    Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen receptor assay in primary breast cancer: clinical validation and prognostic value.
    Furnival CM; Hillyard NC; Gough IR
    Aust N Z J Surg; 1982 Aug; 52(4):403-8. PubMed ID: 6956317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.
    Barnes DM; Millis RR; Gillett CE; Ryder K; Skilton D; Fentiman IS; Rubens RD
    Endocr Relat Cancer; 2004 Mar; 11(1):85-96. PubMed ID: 15027887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma.
    Raabe NK; Hagen S; Haug E; Fossaa SD
    Int J Oncol; 1998 May; 12(5):1091-6. PubMed ID: 9538134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of oestrogen-receptor status to survival in breast cancer.
    Bishop HM; Blamey RW; Elston CW; Haybittle JL; Nicholson RI; Griffiths K
    Lancet; 1979 Aug; 2(8137):283-4. PubMed ID: 88612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol receptor activity in human breast cancer, disease free interval and survival time.
    Heise E; Görlich M
    Anticancer Res; 1982; 2(1-2):33-6. PubMed ID: 7114801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast.
    Williams G; Howell A; Jones M
    Br J Cancer; 1988 Nov; 58(5):631-4. PubMed ID: 3219275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival with breast cancer: the importance of estrogen receptor quantity.
    Shek LL; Godolphin W
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):243-50. PubMed ID: 2702979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.
    Nicholson S; Richard J; Sainsbury C; Halcrow P; Kelly P; Angus B; Wright C; Henry J; Farndon JR; Harris AL
    Br J Cancer; 1991 Jan; 63(1):146-50. PubMed ID: 1846551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.
    Maynard PV; Davies CJ; Blamey RW; Elston CW; Johnson J; Griffiths K
    Br J Cancer; 1978 Dec; 38(6):745-8. PubMed ID: 743491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical data related to oestrogen receptor status in women presenting with breast cancer.
    Montgomery AC; McClelland RA; Skilton RA; Easton D
    Br J Surg; 1985 Aug; 72(8):629-33. PubMed ID: 4027537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen receptors and prognosis in early breast cancer.
    Cooke T; George D; Shields R; Maynard P; Griffiths K
    Lancet; 1979 May; 1(8124):995-7. PubMed ID: 86771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.